by windgap_b3v3vc | Jun 16, 2020 | News & Announcements
Windgap Medical, Inc. announced today that it has finalized a deal to enable a strategic investment from Molex Ventures, LLC, a subsidiary of Koch Industries (“Molex Ventures”). Molex Ventures will be investing in an investment round in Windgap led by the...
by windgap_b3v3vc | Jun 16, 2020 | Accolades & Awards, News & Announcements
The Massachusetts Life Sciences Center (MLSC), a quasi-public agency charged with implementing the state’s 10-year, $1-billion Life Sciences Initiative, announced today the awarding of $2 million in loans to two early-stage life sciences companies. Read the full press...
by windgap_b3v3vc | Jun 16, 2020 | Accolades & Awards
Windgap Medical, Inc. and the University of Minnesota Twin Cities have received a $3.2 million grant from the National Institutes of Health (NIH) to develop a new device to quickly administer a recently developed antidote for cyanide poisoning. Read the full press...
